Private Equity

Following a major legal victory in Peru, American Lithium will spin out its massive Macusani uranium project to capitalize on a surging nuclear energy market.

Pfizer projects lower 2026 earnings as COVID sales wane and patents expire, shifting focus to a multi-billion dollar R&D push for future growth.

The world's largest bamboo resort opens in a Vietnamese heritage site, blending Hmong culture with advanced wellness for a new kind of regenerative travel.

Ayrmid and RoslinCT forge a key manufacturing pact for a new SAA therapy, revealing the critical infrastructure needed for resilient biotech returns.

Private equity giant Apollo is acquiring French food retailer Prosol. A deep dive into the deal, Prosol's unique model, and the future of food retail.

A new office for Lexington Partners reveals Abu Dhabi's rise as a global finance hub and the growing demand for complex liquidity solutions in private markets.

Bluerock is listing its private real estate fund on the NYSE, offering monthly payouts. Is this a game-changer for retail investors or a risky strategic play?

Affluent buyers in Southeast Asia are trading property for lifestyle, fueling a 230% boom in branded residences. Why is experience the new ultimate luxury?

A decade-long wait ends as the FDA approves a new 1st-line therapy for HER2+ breast cancer. See how ENHERTU reshapes patient outcomes and market dynamics.

IO Biotech’s cancer vaccine posts impressive 5-year survival data, but a narrow miss in its pivotal trial creates an uncertain path in a competitive market.

Varsity Healthcare Partners' new foundation applies investment-grade rigor to its giving, funding charities with measurable health and wellness impacts.

Beijing touts its Sanjiangyuan project as a win for ecology and herders. But beyond the state narrative lies a complex story of coercion and cultural risk.

NineDot Energy is leveraging battery storage to deliver $60M in energy credits, tackling NYC's affordability crisis and retiring polluting power plants.

Bringer Air Cargo's new direct route to Navegantes isn't just a flight path; it's a strategic move reshaping supply chains for Brazil's economic engine.

SEG Solar's $80M Indonesian plant isn't just a new factory; it's a strategic move to build a non-FEOC solar supply chain for the United States.

This new partnership is more than a sponsorship. It's a strategic move to close the gender data gap in sports science and redefine athlete care for women.

AMTD Digital's subsidiary is on a global hotel buying binge, but a history of extreme stock volatility and underlying financial risks raise serious questions.

After a NYSE delisting, FOXO Technologies is betting big on healthcare acquisitions. Is this a savvy turnaround or a high-risk gamble for investors?

As Spruce Biosciences preps its rare disease drug for FDA review, the addition of a commercial veteran signals a high-stakes shift from R&D to market.

A fintech firm's new hire seems distant, but it signals a crucial shift in how capital flows into life-saving research and healthcare innovation.